Exclusive: Third death revealed in China's popular but opaque trials

A patient with an autoimmune disease has died after receiving an experimental genetic medicine from a biotech startup in China, Endpoints News has learned. The Shanghai-based company, RiboX Therapeutics, recently received a green light from ...